&w=3840&q=100)
Hyundai Motor shares rally 7%, hit all-time high; what's behind the surge?
Hyundai Motor India share price today: The stock price of the passenger cars & utility vehicles company surpassed its previous high of ₹1,968.80, which it recorded on the listing day
Mumbai
Listen to This Article
Hyundai Motor India share price today
Shares of Hyundai Motor India hit a record high of ₹1,986.60 per share, as they rallied 7 per cent on the BSE in Monday's intraday trade amid heavy volumes, on expectation of a healthy outlook.
The stock price of the passenger cars & utility vehicles company surpassed its previous high of ₹1,968.80, which it recorded on the listing day i.e. October 22, 2024. Hyundai Motor India raised ₹27,870 crore via its IPO at an issue price of ₹1,960 per share.
Hyundai Motor shares have bounced back 29 per cent from their 52-week low of
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
an hour ago
- Hindustan Times
RCB's parent company reacts to 'plans to sell' franchise after winning IPL
Rumours of the Royal Challengers Bengaluru (RCB) being on sale surfaced just days after the franchise claimed its maiden Indian Premier League (IPL) title after beating Punjab Kings in Ahmedabad. However, the owners, Diageo India, an Indian branch of UK-based Diageo Plc, categorically shut the rumours as they told the Bombay Stock Exchange (BSE) and BSE Surveillance Department on Tuesday that the reports were merely speculative in nature. Earlier, a Bloomberg report indicated that the British distiller has been in discussion with potential advisers on selling part or all of the club. Diageo owns the team through its Indian unit, United Spirits Ltd., and may seek a valuation of as much as $2 billion. However, the rumours were ended in a mail to the BSE, with Mital Sanghvi, the company secretary, informing the regulating body of the Indian Stock Market, "The company would like to clarify that the aforesaid media reports are speculative in nature and it is not pursuing any such discussion. This is for your information and records." Diageo is registered with the BSE and hence a mail was sent to the company as the rumours around the RCB had lifted the share price. Shares of United Spirits gained as much as 3.3%, to hit a five-month high, in Mumbai trading on Tuesday morning following the report on potential deal. The rumours emerged at a time when India's health ministry is keen on banning the promotion of tobacco and alcohol brands in the IPL. While advertisement of such products are strictly prohibited in India, Diageo have promoted other products such as soda using top cricketers. The discussions also emerged at a time when RCB found themselves in the midst of a controversy after the unfortunate incident outside the Chinnaswamy on June 4. The franchise had arranged a celebration in the city a day after the IPL win, which saw around 2.5 lakh fans gathering in and around the home stadium in Bengaluru. But all turned into a chaos as a stampede saw 11 people losing their lives, while 56 were left injured. The incident has drawn criticism from local authorities and increased scrutiny over event safety, adding pressure on the franchise's ownership as it faces reputational risks tied to the tragedy.
Time of India
an hour ago
- Time of India
Sustained capacity addition, PPA tie ups improve revenue visibility for Acme Solar
The stock of Acme Solar Holdings , a renewable energy producer, has gained 18% on bourses in a month following strong fourth quarter performance in terms of double digit revenue and profit growth and improved power generation. The company continues to expand the operational capacity of its projects, which is fully tied up to long term power purchase agreements (PPA) with central and state government agencies thereby offering revenue visibility. Analysts anticipate a strong revenue and profit growth annually between FY25 and FY28. The company builds, owns, and operates renewable energy projects in solar, wind, hybrid and firm and dispatchable renewable energy (FDRE) categories. FDRE offers firm power supply at higher capacity utilisation factor (CUF) compared with solar and wind projects. On June 10, Acme announced commissioning of 75 megawatts (MW) of renewable energy capacity at its project in Sikar, Rajasthan, which follows a 165 MW addition in May taking the commissioned capacity to 240 MW out of planned capacity of 300 MW. This has also enhanced its total operational capacity to 2,806 MW as of June 10, 2025 from 1,340 MW a year ago. It has another 4,164 MW of capacity at various stages of implementation, which is expected to be commissioned by FY28. In FY25, the company's power generation increased by 55.2% to 4,013 million units, driven by improved operational capacity and an increase in CUF to 25.6% in FY25 from 23.6% in the previous year. The company monetised 369 MW of assets in FY25. Excluding that, revenue grew by 32.3% year-on-year to Rs1,575 crore while net profit surged nearly four times to Rs 251 crore in FY25. Acme's asset base expanded by 36% to Rs15,507 crore while net worth grew by 74% to Rs4,509 crore, helped by an initial public offering (IPO) in November wherein it raised Rs 2,395 crore of fresh equity. The stock has been under pressure since its public listing on November 13, mostly trading below the offer price of Rs 289 given the hangover of additional stake sale by the promoter group to reduce its holding from 83.4% to 75% or below to abide by the regulatory requirement. 'Given the company's discernible execution performance and visibility on upcoming capacity, we estimate revenue and EBITDA to grow by 54% and 57% over FY25-28,' stated JM Financial Research in a report. It has a buy call on ths tock with a target price of Rs270. The stock was last traded at Rs252.8 on Tuesday on the BSE.
Business Standard
2 hours ago
- Business Standard
Aayush Wellness Limited to Form Wholly Owned Subsidiary in Singapore to Drive Southeast Asia Expansion
VMPL New Delhi [India], June 10: Aayush Wellness Limited [BSE:539528], an integrated healthcare company dedicated to holistic wellness and innovation, is pleased to announce that its Board of Directors has approved the formation of a wholly owned subsidiary in Singapore with an initial capital investment of SGD 10,000. Highlights:- * Aayush Wellness Limited Stock Price at 52 week High of Rs. 151.05 per share * Income from Operations jump multifold to Rs. 73.34 crore in FY 2024-25 * Net Profit for FY 25 was reported at Rs. 3.05 crore, 434% rise Y-o-Y * Company is planning expansion into preventive healthcare with Smart Health Kiosks & Medical Support centre; To Invest upto Rs. 25 crore in the expansion This strategic expansion marks a significant step in the company's global growth strategy and will serve as a launchpad for its nutraceutical and healthcare products across the rapidly expanding Southeast Asian markets. Mr. Naveena Kumar, Managing Director of Aayush Wellness said, "Our new Singapore-based subsidiary will enable us to tap into one of the world's most dynamic wellness markets, offering greater agility in operations, regulatory efficiency, and direct access to high-growth ASEAN economies. This is a critical step toward building a global wellness brand." Unlocking Regional Potential: The Southeast Asian nutraceutical market is projected to reach USD 15.1 billion by 2028, growing at a CAGR of 7.5%, driven by rising health consciousness, urbanization, and preference for preventive healthcare solutions. Singapore, in particular, stands out as a key market and gateway for regional expansion. The country's nutraceutical sector is valued at over USD 1.3 billion, with steady growth driven by an aging population, high per capita health spending, and a consumer base that actively seeks functional foods, dietary supplements, and herbal wellness solutions. Its strong regulatory framework and international connectivity make it an ideal base for Aayush Wellness's global ambitions. Key Focus Areas of the Subsidiary: * Localizing product offerings to align with regulatory and cultural preferences. * Forging strategic partnerships and e-commerce distribution channels across ASEAN. * Driving export growth from India while expanding the company's international brand presence. * Establishing a regional R & D and innovation hub to adapt to market-specific wellness trends. Aligned with Aayush Wellness's Vision: This development is in line with Aayush Wellness Limited's broader mission to deliver science-backed, sustainable, and natural healthcare solutions globally. The company aims to use its new presence in Singapore to not only access markets in Malaysia, Indonesia, Thailand, and Vietnam, but also to establish a foundation for future global partnerships and innovation. For the Financial year 2024-25 ended 31st March 2025. company has reported income from operations of Rs. 73.34 crore for FY2024-25, multifold growth as compared to the income from operations of Rs. 60 lakh in the corresponding period last year. Net profit of the company for the FY 2024-25 was reported at Rs. 3.05 crore, 434% rise Y-o-Y as compared to the net profit of Rs. 57 lakh in the corresponding period in FY 2023-24. The stock price was up and touched 52 week high of Rs. 151.05 per share on 9 June 2025. The share price was in the buyer circuit for the last many days with good volumes. Aayush Wellness is also taking ambitious strides into offline preventive healthcare. Company has launched its first healthcare centre in Virar (Mumbai), Maharashtra. Inspired by the E Sanjeevani National Telemedicine Service of the Ministry of Health and Family Welfare, Aayush Wellness has installed a health ATM that shall conduct a wide range of diagnostics tests, in 2-3 minutes, maintain digital health records, and also facilitate Telemedicine to address health deficiencies before they become critical. The Company plans to invest up to Rs. 25 crores in the first phase and shall review further investments based on business requirements. This expansion will increase company's physical presence across geographies all over India, improve the offline distribution network for our products and provide complete preventive healthcare solutions under one roof. The Cloud Clinic model through this Health ATM is unique as it will deliver affordable yet high quality healthcare services to under privileged population of India. Solution offer by the company not only promotes early detection and prevention but also empowers individuals, especially those in rural and semi-urban areas, to take charge of their health in an accessible, cost-effective manner." The health ATM shall be able to conduct a up to 59 test including blood test, sugar test, Urine test, Haemoglobin test, skin test, eye test, cancer risk test, Lipid Profile test, and other basic health checkups, at a very affordable price. Further, the health ATM shall also facilitate Telemedicine, maintain Digital Health Records, Cloud connectivity generates smart reports and integration with Ayushman Bharat Digital Mission to benefit majority of the Indian Population About Aayush Wellness Limited: (ISO 9000 and 22000 certified company) Aayush Wellness Limited [BSE scrip code: 539528], established in 1989 is a pioneering name in health and wellness solutions, dedicated to offering products that merge wellbeing with innovation. We are India's preventive healthcare company committed to offer quality products and services to enhance the consumer well-being. Aayush Wellness continues to lead the industry in promoting healthier lifestyle choices through its diverse range of wellness products and services. For more information, please visit
